First line immunotherapy combination fails to improve overall survival in lung cancer
by European Society for Medical OncologyStudy author Dr Naiyer Rizvi, director of thoracic oncology and immunotherapeutics, Columbia University Medical Center, New York, US. Credit: © European So
Updated on: May 23,2024
6

First line immunotherapy combination fails to improve overall survival in lung cancer
by European Society for Medical OncologyStudy author Dr Naiyer Rizvi, director of thoracic oncology and immunotherapeutics, Columbia University Medical Center, New York, US. Credit: © European So
Updated on:May 23,2024
6
